{'fraction_non_alphanumeric': 0.034782608695652174, 'fraction_numerical': 0.009782608695652175, 'mean_word_length': 5.485915492957746, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Diagnostic efficiency of the rapid "SEROCHEK MBT" test for the determination of antibodies to mycobacterium tuberculosis].

The informative value of the rapid "SEROCHEK MBT" test (Zephyr Biomedicals, India) was assessed to confirm the presence of serum Mycobacterium tuberculosis antibodies in vitro. Analysis of the findings indicates that pulmonary tuberculosis can be verified by the "SEROCHEK" test only in 31% of the examinees. The tests have proven to be least informative in minor forms of tuberculosis (9%) and to be more informative in disseminated processes (41.7%) and chronic pulmonary tuberculosis (75%). The findings (9% positive serological tests in minor forms of tuberculosis) suggest that the "SEROCHEK MBT" test shows a low sensitivity in confirming the presence of serum Mycobacterium tuberculosis antibodies and therefore a low informative value as a method for the rapid diagnosis of tuberculosis.